Patients who experience an adverse change in employment—such as being laid off—after a heart attack reportedly have a lower quality of life, increased depression and more difficulty affording medications, according to a study published in Circulation on June 12.

An advanced blood test to diagnose heart attacks, currently in development by researchers at King’s College London, could be administered using a handheld device, according to research presented on June 5 at the British Cardiovascular Society conference in Manchester, U.K.

Patients who utilize a healthy lifestyle smartphone application may be able to slow arterial aging, according to results from the EVIDENT II trial presented at EuroHeartCare 2018 in Dublin.

The introduction of high-sensitivity cardiac troponin T (hs-cTnT) in Sweden was associated with an 11 percent reduction in reinfarctions among heart attack patients and increased use of coronary angiography and revascularization, according to a study published June 4 in the Journal of the American College of Cardiology.

Updating the 2013 pooled cohort equations (PCEs) with more recent patient populations and new statistical methods results in approximately 11.8 million U.S. adults migrating to a lower-risk category, potentially affecting which therapies they would be indicated for to combat atherosclerosis.

A compound found in green tea can break up the plaque that causes atherosclerosis, according to research published May 31 in the Journal of Biological Chemistry.

WAYNE, N.J., May 25, 2018 — Getinge, a leading global provider of innovative medical technology, today announced results from the Survival Improvement in Extensive Myocardial Infarction with PERsistent Ischemia Following IABP Implantation (SEMPER FI) pilot study.

About 10 percent of people who suffer a type 1 myocardial infarction (MI) at age 50 or younger use cocaine or marijuana, according to a new study, and these individuals showed double the risk of cardiovascular or all-cause death over extended follow-up.